Oppenheimer Lowers Xylem Target to $135 From $150, Keeps Outperform
Oppenheimer cut its price target on Xylem to $135 from $150 and kept an Outperform rating, according to Dow Jones Newswires citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Oppenheimer lowered its price target on Xylem shares to $135 from $150 while keeping its Outperform rating, Dow Jones Newswires reported, citing Benzinga ratings data. The update was published at 12:55 GMT.
The report does not give reasons for the revision.
why it matters
Target changes from a single broker usually have a limited effect on a stock's price. Investors tend to focus on the analyst's reasoning and on how the consensus view of the shares shifts.
tags
instruments
sources
- Xylem Price Target Cut to $135.00/Share From $150.00 by Oppenheimer — Dow Jones Newswires, 28 October 2026 at 12:55 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗